reviewTop 1% cited
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
Nature Reviews Drug Discovery · 2004 · Vol. 3(5) · pp. 391–400
Napoleone Ferrara✉(Gene Therapy Laboratory)Kenneth J. HillanHans‐Peter Gerber(Molecular Oncology (United States))William Novotny
Angiogenesis and VEGF in CancerCancer Treatment and PharmacologyCancer, Hypoxia, and MetabolismBevacizumabAngiogenesisMedicineVascular endothelial growth factorMonoclonal antibodyCancer researchColorectal cancerCancerVEGF receptorsAntibody
MeSH terms
BevacizumabAnimalsAntibodies, MonoclonalDrug Administration ScheduleHumansColorectal NeoplasmsSurvival AnalysisRandomized Controlled Trials as TopicAngiogenesis InhibitorsVascular Endothelial Growth Factor AAntibodies, Monoclonal, Humanized
Citations
2,577
FWCI
40.47
field-weighted impact
References
164
Percentile
100%
vs. same field & year
Citations per year
Cited by
Vascular Endothelial Growth Factor
Arteriosclerosis Thrombosis and Vascular Biology · 2009 · 1,271 citations
Classification of current anticancer immunotherapies
Oncotarget · 2014 · 467 citations
Evolution of Cancer Pharmacological Treatments at the Turn of the Third Millennium
Frontiers in Pharmacology · 2018 · 869 citations
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Nature Reviews Drug Discovery · 2006 · 1,556 citations
Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy
Biochemical and Biophysical Research Communications · 2005 · 965 citations
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
Angewandte Chemie International Edition · 2014 · 2,114 citations
Protein therapeutics: a summary and pharmacological classification
Nature Reviews Drug Discovery · 2007 · 2,066 citations
Cancer genes and the pathways they control
Nature Medicine · 2004 · 4,243 citations
References
A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
The EMBO Journal · 1996 · 1,679 citations
The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing
Journal of Biological Chemistry · 1991 · 1,983 citations
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Nature Cell Biology · 2000 · 2,775 citations
ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESIS
The Journal of Experimental Medicine · 1971 · 1,661 citations
Tumor Angiogenesis: Therapeutic Implications
New England Journal of Medicine · 1971 · 10,087 citations
Vascular Endothelial Growth Factor Regulates Endothelial Cell Survival through the Phosphatidylinositol 3′-Kinase/Akt Signal Transduction Pathway
Journal of Biological Chemistry · 1998 · 1,982 citations
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
Biochemical and Biophysical Research Communications · 1992 · 1,524 citations
The Biology of Vascular Endothelial Growth Factor
Endocrine Reviews · 1997 · 4,356 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.